When it comes to the Tasmanian tiger, human influence can be blamed for its extinction. But science might have a way to ...

The global recombinant plasma protein therapeutics market is a dynamic and rapidly growing sector within the ...

Nov. 19, 2024 — Leveraging a unique statistical analysis and applying it to ancient DNA extracted from human skeletal remains, a team of researchers has revealed new insights into how ancient ...

To activate certain genes during growth, scientists reversed the process. This suggests that by employing recombinant DNA technology, the nutritional content of many more food crops may be improved.

QIAGEN’s generosity doesn’t end with the donation of the dPCR instrument. In addition to the training session, the company is ...

Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) and Ginkgo Bioworks (NYSE:DNA – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two ...

Spanning DNA synthesis to rAAV production, the Xcell rAAV Platform provides gene therapy companies with an integrated solution for generating high-quality rAAV candidates, supported by a comprehensive ...

A short strangle on Eli Lilly will generate $1,125 in option premium and takes advantage of the current high level of implied volatility.

NORDITROPIN is a polypeptide hormone of recombinant DNA origin. The hormone is synthesized by a special strain of E. coli ...

SkyQuest projects that the global pyrogen testing market size will reach a value of USD 4.10 Billion by 2031 , with a CAGR of 13.4% during the forecast period (2024-2031). Growing demand for pyrogen ...

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immunodeficiencies, infectious diseases and checkpoint-resistant cancers, and a subsidiary of Grifols, announced today ...

A Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a ...